JP2017522907A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017522907A5 JP2017522907A5 JP2017524123A JP2017524123A JP2017522907A5 JP 2017522907 A5 JP2017522907 A5 JP 2017522907A5 JP 2017524123 A JP2017524123 A JP 2017524123A JP 2017524123 A JP2017524123 A JP 2017524123A JP 2017522907 A5 JP2017522907 A5 JP 2017522907A5
- Authority
- JP
- Japan
- Prior art keywords
- coronavirus
- seq
- replicase gene
- leu
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1413020.7 | 2014-07-23 | ||
| GBGB1413020.7A GB201413020D0 (en) | 2014-07-23 | 2014-07-23 | Coronavirus |
| PCT/GB2015/052124 WO2016012793A1 (en) | 2014-07-23 | 2015-07-23 | Coronavirus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017522907A JP2017522907A (ja) | 2017-08-17 |
| JP2017522907A5 true JP2017522907A5 (enExample) | 2018-05-31 |
| JP6712268B2 JP6712268B2 (ja) | 2020-06-17 |
Family
ID=51494985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017524123A Active JP6712268B2 (ja) | 2014-07-23 | 2015-07-23 | コロナウイルス |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10130701B2 (enExample) |
| EP (2) | EP3172319B1 (enExample) |
| JP (1) | JP6712268B2 (enExample) |
| KR (1) | KR20170032441A (enExample) |
| CN (2) | CN106536723B (enExample) |
| AU (1) | AU2015293633B2 (enExample) |
| BR (1) | BR112017001310B1 (enExample) |
| CA (1) | CA2953677C (enExample) |
| DK (1) | DK3172319T3 (enExample) |
| ES (1) | ES2764275T3 (enExample) |
| GB (1) | GB201413020D0 (enExample) |
| HU (1) | HUE047953T2 (enExample) |
| IL (1) | IL249340A0 (enExample) |
| MX (1) | MX373792B (enExample) |
| PL (1) | PL3172319T3 (enExample) |
| PT (1) | PT3172319T (enExample) |
| WO (1) | WO2016012793A1 (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7289268B2 (ja) * | 2017-03-03 | 2023-06-09 | ロヨラ ユニバーシティ シカゴ | コロナウイルス、コロナウイルスを備えるワクチン、および疾患予防方法 |
| MY206043A (en) * | 2018-10-31 | 2024-11-26 | Boehringer Ingelheim Vetmedica Gmbh | H52 ibv vaccine with heterologous spike protein |
| KR102119875B1 (ko) * | 2019-03-19 | 2020-06-05 | 한국화학연구원 | 한국형 중동호흡기증후군 코로나바이러스 감염성 변이 유전자 및 이의 용도 |
| EP3966318A1 (en) | 2019-05-10 | 2022-03-16 | Boehringer Ingelheim Vetmedica GmbH | Attenuated ibv with extended cell culture and tissue tropism |
| EP3966228A1 (en) | 2019-05-10 | 2022-03-16 | Boehringer Ingelheim Vetmedica GmbH | Modified s2 subunit of the coronavirus spike protein |
| CN111254155A (zh) * | 2020-01-25 | 2020-06-09 | 王跃驹 | 一种植物作为宿主表达病毒疫苗的方法 |
| KR20220151168A (ko) | 2020-02-09 | 2022-11-14 | 엔엘씨 파르마 엘티디 | Sars-cov-2에 대한 신속한 검출 테스트 |
| US20230117744A1 (en) * | 2020-03-23 | 2023-04-20 | Loyola University Of Chicago | Coronavirus vaccines compositions and method of using same |
| WO2021203236A1 (zh) * | 2020-04-07 | 2021-10-14 | 四川骋誉生物制品有限公司 | 用于预防covid-19的蝙蝠源性冠状病毒疫苗 |
| US12558415B2 (en) | 2020-04-14 | 2026-02-24 | The Regents Of The University Of California | Broad-spectrum multi-antigen pan-coronavirus vaccine |
| US20220033383A1 (en) | 2020-07-20 | 2022-02-03 | Enanta Pharmaceuticals, Inc. | Functionalized peptides as antiviral agents |
| CN112029781B (zh) * | 2020-08-14 | 2023-01-03 | 中山大学 | 一种新型冠状病毒SARS-CoV-2的安全型复制子系统及其应用 |
| JP2024004496A (ja) * | 2020-10-14 | 2024-01-17 | 一般財団法人阪大微生物病研究会 | ノックアウトコロナウイルス |
| KR20230124583A (ko) | 2020-11-23 | 2023-08-25 | 이난타 파마슈티칼스, 인코포레이티드 | 신규한 스피로피롤리딘 유래 항바이러스제 |
| US11352363B1 (en) | 2020-11-23 | 2022-06-07 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US11384090B2 (en) | 2020-11-23 | 2022-07-12 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US12540141B2 (en) | 2020-11-23 | 2026-02-03 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| CN112592905B (zh) * | 2020-12-28 | 2023-07-28 | 广州达安基因股份有限公司 | 用于新型冠状病毒检测的dna聚合酶混合物 |
| CN114751964B (zh) * | 2020-12-29 | 2024-03-08 | 苏州方舟生物科技有限公司 | β属冠状病毒通用疫苗蛋白片段及其筛选方法和应用 |
| WO2022235605A1 (en) | 2021-05-04 | 2022-11-10 | Enanta Pharmaceuticals, Inc. | Novel macrocyclic antiviral agents |
| US12398147B2 (en) | 2021-05-11 | 2025-08-26 | Enanta Pharmaceuticals, Inc. | Macrocyclic spiropyrrolidine derived antiviral agents |
| US11319325B1 (en) | 2021-05-11 | 2022-05-03 | Enanta Pharmaceuticals, Inc. | Macrocyclic spiropyrrolidine derived antiviral agents |
| CN113308440B (zh) * | 2021-05-26 | 2023-04-28 | 武汉大学 | 一种n7-甲基转移酶缺陷型冠状病毒减毒疫苗株及其制备方法与应用 |
| US11325916B1 (en) | 2021-07-29 | 2022-05-10 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US11339170B1 (en) | 2021-07-23 | 2022-05-24 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US12479854B2 (en) | 2021-07-29 | 2025-11-25 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| EP4404946A4 (en) * | 2021-09-22 | 2026-01-07 | Biomedit Inc | METHOD FOR INHIBITING DISEASES SURRIDATED BY RESPIRATORY VIRUSES |
| US11912714B2 (en) | 2021-11-12 | 2024-02-27 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US11919910B2 (en) | 2021-11-12 | 2024-03-05 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US11858945B2 (en) | 2021-11-12 | 2024-01-02 | Enanta Pharmaceuticals, Inc. | Alkyne-containing antiviral agents |
| WO2023107419A1 (en) | 2021-12-08 | 2023-06-15 | Enanta Pharmaceuticals, Inc. | Saturated spirocyclics as antiviral agents |
| US12145941B2 (en) | 2021-12-08 | 2024-11-19 | Enanta Pharmaceuticals, Inc. | Heterocyclic antiviral agents |
| WO2023196307A1 (en) | 2022-04-05 | 2023-10-12 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| WO2024191944A2 (en) * | 2023-03-10 | 2024-09-19 | The Regents Of The University Of California | Broad-spectrum multi-antigen pan-coronavirus vaccine |
| CN121941508A (zh) * | 2023-09-11 | 2026-04-28 | 勃林格殷格翰动物保健(中国)有限公司 | 减毒的传染性支气管炎病毒和包含其的疫苗 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004078203A2 (en) | 2003-03-03 | 2004-09-16 | Akzo Nobel N.V. | Infectious bronchitis virus with an altered spike gene |
| ES2529736T3 (es) | 2003-04-10 | 2015-02-25 | Novartis Vaccines And Diagnostics, Inc. | Composición inmunogénica que comprende una proteína espicular del coronavirus del SARS |
| EP1533370A1 (en) * | 2003-11-18 | 2005-05-25 | ViroNovative B.V. | Novel atypical pneumonia-causing virus |
| CN100413537C (zh) * | 2004-01-29 | 2008-08-27 | 国家人类基因组南方研究中心 | Sars冠状病毒全病毒疫苗 |
| US7452542B2 (en) * | 2004-05-21 | 2008-11-18 | Vanderbilt University | Live attenuated coronavirus vaccines |
| WO2007078203A1 (en) | 2006-01-03 | 2007-07-12 | Norwex Holding As | Anti-bacterial micro-fibre and production thereof |
| GB0911794D0 (en) * | 2009-07-07 | 2009-08-19 | Animal Health Inst | Chimaeric protein |
| CN102851257A (zh) * | 2012-08-27 | 2013-01-02 | 上海启盛生物科技有限公司 | 一种鸡传染性支气管炎病毒减毒疫苗株及其应用 |
| CN103397002A (zh) * | 2013-08-07 | 2013-11-20 | 广东温氏食品集团股份有限公司 | 禽传染性支气管炎病毒的致弱方法 |
-
2014
- 2014-07-23 GB GBGB1413020.7A patent/GB201413020D0/en not_active Ceased
-
2015
- 2015-07-23 EP EP15750093.5A patent/EP3172319B1/en active Active
- 2015-07-23 CN CN201580037402.1A patent/CN106536723B/zh active Active
- 2015-07-23 JP JP2017524123A patent/JP6712268B2/ja active Active
- 2015-07-23 CN CN202411677449.1A patent/CN120098946A/zh active Pending
- 2015-07-23 AU AU2015293633A patent/AU2015293633B2/en active Active
- 2015-07-23 CA CA2953677A patent/CA2953677C/en active Active
- 2015-07-23 ES ES15750093T patent/ES2764275T3/es active Active
- 2015-07-23 US US15/328,179 patent/US10130701B2/en active Active
- 2015-07-23 PL PL15750093T patent/PL3172319T3/pl unknown
- 2015-07-23 BR BR112017001310-0A patent/BR112017001310B1/pt active IP Right Grant
- 2015-07-23 DK DK15750093.5T patent/DK3172319T3/da active
- 2015-07-23 WO PCT/GB2015/052124 patent/WO2016012793A1/en not_active Ceased
- 2015-07-23 KR KR1020177004614A patent/KR20170032441A/ko not_active Ceased
- 2015-07-23 EP EP19208113.1A patent/EP3656856B1/en active Active
- 2015-07-23 MX MX2016016722A patent/MX373792B/es active IP Right Grant
- 2015-07-23 HU HUE15750093A patent/HUE047953T2/hu unknown
- 2015-07-23 PT PT157500935T patent/PT3172319T/pt unknown
-
2016
- 2016-12-01 IL IL249340A patent/IL249340A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017522907A5 (enExample) | ||
| JP6712268B2 (ja) | コロナウイルス | |
| Bande et al. | Progress and challenges toward the development of vaccines against avian infectious bronchitis | |
| CN102574897B (zh) | 嵌合蛋白 | |
| WO2008061939A1 (en) | Recombinant modified vaccinia virus ankara (mva)-based vaccine for the avian flu | |
| JP2008522621A (ja) | 世界的に流行するトリインフルエンザに対して迅速に応答するためのワクチン | |
| RU2018130683A (ru) | Аттенуированный вирус инфекционного бронхита | |
| US20210205436A1 (en) | Recombinant mopeia virus and vaccine platform | |
| JP5675789B2 (ja) | 免疫接種のための発現ベクターとしての水疱性口内炎ウイルスの異なる複数の抗原型 | |
| JP4691495B2 (ja) | コロナウイルススパイクｓ１融合蛋白及びその発現ベクター | |
| US9969777B2 (en) | Mutant spike protein extending the tissue tropism of infectious bronchitis virus (IBV) | |
| Wang et al. | Parainfluenza virus 5 is a next‐generation vaccine vector for human infectious pathogens | |
| CN106520710A (zh) | 表达鸭坦布苏病毒prm和E蛋白重组新城疫病毒活载体疫苗的制备及应用 | |
| CA2962100A1 (en) | Virus-based expression vectors and uses thereof | |
| CN115768472A (zh) | 包含具有特定基因顺序的核酸构建体的甲型猪流感病毒疫苗 | |
| CN115697398A (zh) | 包含两种不同rna复制子颗粒的甲型猪流感病毒疫苗 | |
| CN121752290A (zh) | Dev作载体的禽流感h9疫苗 | |
| TW202400800A (zh) | 用於預防和治療狂犬病毒感染的組合物和方法 | |
| CN115768785A (zh) | 包含含有编码病毒的不同神经氨酸酶抗原的第一、第二和第三核酸序列的核酸构建体的甲型猪流感病毒疫苗 | |
| RU2012117014A (ru) | Способ получения рекомбинантного капсидного белка вируса гепатита е. рекомбинантная вакцина для профилактики вирусного гепатита е. | |
| JP2004508814A (ja) | タンデム配置された２つの遺伝子をコードする２シストロンｖＲＮＡを担持する組換えインフルエンザウイルス | |
| CN121843706A (zh) | 用于禽类疫苗的新型dev载体 | |
| JP2025513753A (ja) | ワントゥーストップ（ｏｎｅ－ｔｏ－ｓｔｏｐ）弱毒化ＳＡＲＳ－ＣｏＶ－２ウイルス | |
| JP2006121948A (ja) | 組換えウイルス | |
| EA052121B1 (ru) | Композиции и способы профилактики и лечения инфекции, вызванной вирусом бешенства |